Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on LinkedIn:
“Honored to have the opportunity to open the ESMO GYN Conference 2026 with a Keynote Lecture on the arrival of Antibody Drug Conjugates.
Two ADCs already approved for GYN tumors, many more to come, and major pending questions which will need cross-disease collaborations to be answered.”
Other articles about ESMO on OncoDaily.
